Edition:
United States

Aethlon Medical Inc (AEMD.OQ)

AEMD.OQ on NASDAQ Stock Exchange Capital Market

1.26USD
2:28pm EST
Change (% chg)

$0.04 (+3.28%)
Prev Close
$1.22
Open
$1.25
Day's High
$1.36
Day's Low
$1.23
Volume
168,876
Avg. Vol
100,510
52-wk High
$5.17
52-wk Low
$0.80

Latest Key Developments (Source: Significant Developments)

Aethlon Medical announces second quarter results
Thursday, 2 Nov 2017 04:15pm EDT 

Nov 2 (Reuters) - Aethlon Medical Inc :Aethlon Medical announces fiscal 2018 second quarter results.Q2 loss per share $0.14.  Full Article

AETHLON MEDICAL ANNOUNCES PRODUCTION COLLABORATION WITH IBIO INC
Monday, 16 Oct 2017 07:15am EDT 

Oct 16 (Reuters) - Aethlon Medical Inc ::AETHLON MEDICAL ANNOUNCES LARGE-SCALE PRODUCTION COLLABORATION.AETHLON MEDICAL INC - HAS ESTABLISHED A COLLABORATION WITH IBIO INC. TO SUPPORT POTENTIAL LARGE-SCALE PRODUCTION OF AETHLON HEMOPURIFIER​.  Full Article

IBIO ANNOUNCES MANUFACTURING COLLABORATION WITH AETHLON MEDICAL
Monday, 16 Oct 2017 07:15am EDT 

Oct 16 (Reuters) - iBio Inc ::IBIO ANNOUNCES MANUFACTURING COLLABORATION WITH AETHLON MEDICAL.IBIO INC - ‍AGREEMENT WITH AETHLON MEDICAL INC TO SUPPORT POTENTIAL LARGE-SCALE PRODUCTION OF AETHLON HEMOPURIFIER BLOOD PURIFICATION DEVICE​.  Full Article

Intracoastal Capital reports 5.7 pct passive stake in Aethlon Medical
Wednesday, 11 Oct 2017 06:09pm EDT 

Oct 11 (Reuters) - Aethlon Medical Inc :Intracoastal Capital LLC reports 5.7 percent passive stake in Aethlon Medical Inc as of Oct 2 - SEC filing‍​.  Full Article

Aethlon Medical received formal receipt from FDA for expedited access pathway program submission ‍​
Monday, 14 Aug 2017 03:38pm EDT 

Aug 14 (Reuters) - Aethlon Medical Inc ::On Aug 14, co received formal receipt from the U.S. FDA for expedited access pathway program submission ‍​.Submission formally requests that the Aethlon Hemopurifier be included in the FDA EAP program - SEC filing‍​.  Full Article

Aethlon Medical reports Q1 loss per share $0.21
Thursday, 10 Aug 2017 04:15pm EDT 

Aug 10 (Reuters) - Aethlon Medical Inc -:Aethlon Medical announces fiscal 2018 first quarter results.Q1 loss per share $0.21.Aethlon Medical - ‍finalized expedited access pathway program submission that its regulatory advisors will provide to united states FDA.Aethlon Medical Inc - ‍finalized submission requests that aethlon hemopurifier be included in eap program​.  Full Article

Aethlon Medical Inc files for stock offering of up to $13.3 mln - SEC filing
Monday, 31 Jul 2017 04:46pm EDT 

July 31 (Reuters) - Aethlon Medical Inc :Aethlon Medical Inc files for common stock offering of up to $13.3 million - SEC filing.  Full Article

Aethlon Medical ‍announces grant of U.S. patent
Wednesday, 19 Jul 2017 07:11am EDT 

July 19 (Reuters) - Aethlon Medical Inc -:Aethlon Medical Inc - ‍announces grant of a U.S. Patent protecting methods of capturing MHC antigen associated exosomes​.  Full Article

Aethlon Medical plans to submit expedited access pathway program submission to FDA
Wednesday, 28 Jun 2017 04:15pm EDT 

June 28 (Reuters) - Aethlon Medical Inc ::Aethlon Medical announces fiscal 2017 results.Aethlon Medical Inc - now plans to submit an expedited access pathway program submission to FDA.Aethlon Medical - if EAP submission is accepted by FDA, company believes regulatory advancement of hemopurifier could be accelerated in united states.  Full Article

Empery Asset Management LP reports 8.79 pct passive stake in Aethlon Medical as of March 22 - SEC Filing
Monday, 27 Mar 2017 05:46pm EDT 

Aethlon Medical Inc :Empery Asset Management LP reports 8.79 percent passive stake in Aethlon Medical Inc as of March 22 - SEC Filing.  Full Article

BRIEF-Aethlon Medical Names Dr. Charles J. Fisher Chairman Of The Board

* AETHLON MEDICAL NAMES DR. CHARLES J. FISHER CHAIRMAN OF THE BOARD Source text for Eikon: Further company coverage: